UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):

August 23, 2007

 

APOGEE TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

Delaware

 

001-10456

 

04-3005815

(State or other jurisdiction of
incorporation or organization)

 

(Commission
File Number)

 

(IRS employer
identification no.)

 

129 Morgan Drive

Norwood, Massachusetts 02062

(781) 551-9450

(Address, including zip code, and telephone number, including area code,

of registrant’s principal executive offices)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

ITEM 8.01   OTHER EVENTS.

Apogee Technology, Inc. (the “Company”), issued a press release on August 23, 2007 discussing the entry into an Agreement with Vaccine and Infectious Disease Organization.

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference in this Item 8.01.

ITEM 9.01   FINANCIAL STATEMENTS AND EXHIBITS.

(c)  Exhibits

99.1

 

Press release dated August 23, 2007.

 

2



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

APOGEE TECHNOLOGY, INC.

 

 

 

Dated: August 28, 2007

By:

/s/ Herbert M. Stein

 

 

Herbert M. Stein

 

 

President, Chief Executive Officer and

 

 

Chairman of the Board

 

3



 

EXHIBIT INDEX

Exhibit No.

 

Description

99.1

 

Press release dated August 23, 2007.

 

4